| Identification | Back Directory | [Name]
pyridoxamine | [CAS]
85-87-0 | [Synonyms]
Pyridorin
Pyridoxylamine
PyridoxaMine-d4
pyridoxamine USP/EP/BP
4-(aminomethyl)-2-methyl-5-methylol-pyridin-3-ol
4-Aminomethyl-5-hydroxy-6-methyl-3-pyridinemethanol
4-(aminomethyl)-5-(hydroxymethyl)-2-methyl-pyridin-3-ol
3-Pyridinemethanol, 4-(aminomethyl)-5-hydroxy-6-methyl-
3-Hydroxy-5-(hydroxymethyl)-2-methyl-4-pyridinemethanamine
4-(azaniumylmethyl)-5-(hydroxymethyl)-2-methylpyridin-3-olate | [EINECS(EC#)]
201-640-5 | [Molecular Formula]
C8H12N2O2 | [MDL Number]
MFCD00464815 | [MOL File]
85-87-0.mol | [Molecular Weight]
168.2 |
| Chemical Properties | Back Directory | [Melting point ]
193-193.5 °C | [Boiling point ]
460.1±40.0 °C(Predicted) | [density ]
1.282±0.06 g/cm3(Predicted) | [storage temp. ]
Hygroscopic, Refrigerator, under inert atmosphere | [solubility ]
DMSO (Slightly), Methanol (Slightly) | [form ]
Solid | [pka]
9.98±0.10(Predicted) | [color ]
Pale Yellow | [Stability:]
Hygroscopic |
| Hazard Information | Back Directory | [Definition]
ChEBI: Pyridoxamine is a monohydroxypyridine that is pyridine substituted by a hydroxy group at position 3, an aminomethyl group at position 4, a hydroxymethyl group at position 5 and a methyl group at position 2. The 4-aminomethyl form of vitamin B6, it is used (in the form of the hydrochloride salt) for treatment of diabetic nephropathy. It has a role as a human metabolite, a Saccharomyces cerevisiae metabolite, an Escherichia coli metabolite, a plant metabolite, a mouse metabolite, an iron chelator and a nephroprotective agent. It is a hydroxymethylpyridine, a monohydroxypyridine, an aminoalkylpyridine and a vitamin B6. It is a conjugate base of a pyridoxaminium(1+). |
|
|